Exploiting DNA damage without repair: The activity of platinum chemotherapy in BRCA-mutated prostate cancers

Cancer. 2017 Sep 15;123(18):3441-3444. doi: 10.1002/cncr.30806. Epub 2017 Jun 13.

Authors

Michael S Humeniuk¹, Tian Zhang^{1

2}, Andrew J Armstrong^{2

3

4}

Affiliations

¹ Department of Medicine, Duke University Medical Center, Durham, North Carolina.
² Duke Cancer Institute, Durham, North Carolina.
³ Department of Medicine, Division of Medical Oncology and Department of Surgery, Division of Urology, Duke University Medical Center, Durham, North Carolina.
⁴ Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina.

PMID: 28608923
DOI: 10.1002/cncr.30806

No abstract available

Publication types

Editorial
Comment

MeSH terms

BRCA2 Protein
DNA Damage
Germ Cells
Humans
Male
Platinum*
Prostatic Neoplasms*

Substances

BRCA2 Protein
BRCA2 protein, human
Platinum